Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers von Schwieter, Hendrik Reinier, Groen, Edwin W. J., Sollie, Frans A. E., Jonkman, Jan H. G.

Volltext

Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol von RIEMENS, S. C, OOSTDIJK, A, VAN DOORMAAL, J. J, THIJN, C. J. P, DRENT, G, PIERS, D. A, GROEN, E. W. J, MEERMAN, L, SLOOFF, M. J. H, HAAGSMA, E. B

Volltext

Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen von Riemens, S C, Oostdijk, A, van Doormaal, J J, Thijn, C J, Drent, G, Piers, D A, Groen, E W, Meerman, L, Slooff, M J, Haagsma, E B

Volltext

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma von Nijhof, Inger S., Casneuf, Tineke, van Velzen, Jeroen, van Kessel, Berris, Axel, Amy E., Syed, Khaja, Groen, Richard W.J., van Duin, Mark, Sonneveld, Pieter, Minnema, Monique C., Zweegman, Sonja, Chiu, Christopher, Bloem, Andries C., Mutis, Tuna, Lokhorst, Henk M., Sasser, A.Kate, van de Donk, Niels W.C.J.

Volltext

Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells von Thedieck, Kathrin, Holzwarth, Birgit, Prentzell, Mirja Tamara, Boehlke, Christopher, Kläsener, Kathrin, Ruf, Stefanie, Sonntag, Annika Gwendolin, Maerz, Lars, Grellscheid, Sushma-Nagaraja, Kremmer, Elisabeth, Nitschke, Roland, Kuehn, E. Wolfgang, Jonker, Johan W., Groen, Albert K., Reth, Michael, Hall, Michael N., Baumeister, Ralf

Volltext

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands von Cramer-van der Welle, Christine M., Verschueren, Marjon V., Tonn, Merel, Peters, Bas J. M., Schramel, Franz M. N. H., Klungel, Olaf H., Groen, Harry J. M., van de Garde, Ewoudt M. W.

Volltext

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor von Hiltermann, T.J.N., Pore, M.M., van den Berg, A., Timens, W., Boezen, H.M., Liesker, J.J.W., Schouwink, J.H., Wijnands, W.J.A., Kerner, G.S.M.A., Kruyt, F.A.E., Tissing, H., Tibbe, A.G.J., Terstappen, L.W.M.M., Groen, H.J.M.

Volltext

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma von Drent, Esther, Groen, Richard W J, Noort, Willy A, Themeli, Maria, Lammerts van Bueren, Jeroen J, Parren, Paul W H I, Kuball, Jürgen, Sebestyen, Zsolt, Yuan, Huipin, de Bruijn, Joost, van de Donk, Niels W C J, Martens, Anton C M, Lokhorst, Henk M, Mutis, Tuna

Volltext

Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab von Krejcik, Jakub, Frerichs, Kris A, Nijhof, Inger S, van Kessel, Berris, van Velzen, Jeroen F, Bloem, Andries C, Broekmans, Marloes E C, Zweegman, Sonja, van Meerloo, Johan, Musters, René J P, Poddighe, Pino J, Groen, Richard W J, Chiu, Christopher, Plesner, Torben, Lokhorst, Henk M, Sasser, A Kate, Mutis, Tuna, van de Donk, Niels W C J

Volltext

Molecular Tumor Boards: current practice and future needs von van der Velden, D.L., van Herpen, C.M.L., van Laarhoven, H.W.M., Smit, E.F., Groen, H.J.M., Willems, S.M., Nederlof, P.M., Langenberg, M.H.G., Cuppen, E., Sleijfer, S., Steeghs, N., Voest, E.E.

Volltext

The ACE I/D polymorphism does not explain heterogeneity of natural course and response to enzyme replacement therapy in Pompe disease von Kuperus, Esther, van der Meijden, Jan C, In 't Groen, Stijn L M, Kroos, Marian A, Hoogeveen-Westerveld, Marianne, Rizopoulos, Dimitris, Martinez, Monica Yasmin Nino, Kruijshaar, Michelle E, van Doorn, Pieter A, van der Beek, Nadine A M E, van der Ploeg, Ans T, Pijnappel, W W M Pim

Volltext

Microbiome-derived ethanol in nonalcoholic fatty liver disease von Meijnikman, Abraham S., Davids, Mark, Herrema, Hilde, Aydin, Omrum, Tremaroli, Valentina, Rios-Morales, Melany, Levels, Han, Bruin, Sjoerd, de Brauw, Maurits, Verheij, Joanne, Kemper, Marleen, Holleboom, Adriaan G., Tushuizen, Maarten E., Schwartz, Thue W., Nielsen, Jens, Brandjes, Dees, Dirinck, Eveline, Weyler, Jonas, Verrijken, An, De Block, Christophe E. M., Vonghia, Luisa, Francque, Sven, Beuers, Ulrich, Gerdes, Victor E. A., Bäckhed, Fredrik, Groen, Albert K., Nieuwdorp, Max

Volltext

Extension of the Pompe mutation database by linking disease‐associated variants to clinical severity von Niño, Monica Y., in 't Groen, Stijn L.M., Bergsma, Atze J., Beek, Nadine A.M.E., Kroos, Marian, Hoogeveen‐Westerveld, Marianne, Ploeg, Ans T., Pijnappel, W.W.M. Pim

Volltext

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus von Kootte, R. S., Vrieze, A., Holleman, F., Dallinga-Thie, G. M., Zoetendal, E. G., de Vos, W. M., Groen, A. K., Hoekstra, J. B. L., Stroes, E. S., Nieuwdorp, M.

Volltext

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia von Gutierrez, Alejandro, Pan, Li, Groen, Richard W J, Baleydier, Frederic, Kentsis, Alex, Marineau, Jason, Grebliunaite, Ruta, Kozakewich, Elena, Reed, Casie, Pflumio, Francoise, Poglio, Sandrine, Uzan, Benjamin, Clemons, Paul, VerPlank, Lynn, An, Frank, Burbank, Jason, Norton, Stephanie, Tolliday, Nicola, Steen, Hanno, Weng, Andrew P, Yuan, Huipin, Bradner, James E, Mitsiades, Constantine, Look, A Thomas, Aster, Jon C

Volltext

Insights from the supplementary motor area syndrome in balancing movement initiation and inhibition von Potgieser, A R E, de Jong, B M, Wagemakers, M, Hoving, E W, Groen, R J M

Volltext

Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects von Bouter, Kec, Bakker, G J, Levin, E, Hartstra, A V, Kootte, R S, Udayappan, S D, Katiraei, S, Bahler, L, Gilijamse, P W, Tremaroli, V, Stahlman, M, Holleman, F, van Riel, N A W, Verberne, H J, Romijn, J A, Dallinga-Thie, G M, Serlie, M J, Ackermans, M T, Kemper, E M, Willems van Dijk, K, Backhed, F, Groen, A K, Nieuwdorp, M

Volltext

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression von van der Wekken, A J, Kuiper, J L, Saber, A, Terpstra, M M, Wei, J, Hiltermann, T J N, Thunnissen, E, Heideman, D A M, Timens, W, Schuuring, E, Kok, K, Smit, E F, van den Berg, A, Groen, H J M

Volltext

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer von van der Wekken, A J, Pelgrim, R, 't Hart, N, Werner, N, Mastik, M F, Hendriks, L, van der Heijden, E H F M, Looijen-Salamon, M, de Langen, A J, Staal-van den Brekel, J, Riemersma, S, van den Borne, B E, Speel, E J M, Dingemans, A-M C, Hiltermann, T J N, van den Berg, A, Timens, W, Schuuring, E, Groen, H J M

Volltext

The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer von Degens, J.H.R.J., Sanders, K.J.C., de Jong, E.E.C., Groen, H.J.M., Smit, E.F., Aerts, J.G., Schols, A.M.W.J., Dingemans, A.-M.C.

Volltext